MedPath

Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery

Not Applicable
Completed
Conditions
Hypoglycemia
Interventions
Procedure: euglycemic and hypoglycemic clamp
Registration Number
NCT01283126
Lead Sponsor
Joslin Diabetes Center
Brief Summary

The purpose of this study is to find out the effects of hypoglycemia on cognition in healthy individuals and how well changes in (interstitial) tissue glucose levels correlate with changes in cognitive function as compared to blood glucose levels.

Detailed Description

Subjects will undergo hypoglycemic clamps during which interstitial glucose will be measured and cognitive function will be assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • non obese (BMI <30), ages 18-50
Exclusion Criteria
  • renal or hepatic failure

  • cancer or lymphoma

  • malabsorption or malnourishment

  • hypercortisolism

  • alcoholism or drug abuse

  • anemia

  • eating disorder or depression

  • coronary artery disease

  • Arrhythmias

  • hypertension

  • on medications known to affect the blood glucose to be measured such as

  • glucocorticoids

  • on blood thinning agents

    • Pregnant women, breastfeeding women and women who want to become pregnant in the next 6 months will be excluded from the study.
    • Subjects who have donated blood two weeks prior to the study.
    • Allergies to pig derived products (Heparin will be used)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Euglycemic and hypoglycemic clampeuglycemic and hypoglycemic clampSubjects will complete clamp study visit.
Primary Outcome Measures
NameTimeMethod
cognitive function correlation to blood or interstitial glucose1 year

This investigator initiated study will evaluate cognitive function at the onset, during and following recovery from hypoglycemia and will determine if cognitive function correlates better with blood or interstitial glucose concentrations.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Joslin Diabetes Center

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath